# OnCo record testicular (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/testicular/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "testicular" ;
  schema:name "Testicular germ cell tumours"@en ;
  schema:alternateName "Seminoma"@en, "Non-seminomatous germ cell tumour"@en, "NSGCT"@en ;
  schema:description "Testicular germ cell tumours are the most curable adult solid cancer: cisplatin-based chemotherapy cures the large majority even when the disease has spread to distant sites. Today's research is about giving less treatment to the majority who are cured, rescuing the minority who relapse, and limiting lifelong survivorship harms."@en ;
  schema:url <https://onco.cc/cancers/testicular/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Testicular_cancer> ;
  owl:sameAs <http://www.wikidata.org/entity/Q324464> ;
  schema:citation <https://www.nccn.org/guidelines/guidelines-detail?category=1&id=1468>, <https://doi.org/10.1200/JCO.20.03296>, <https://www.cancer.gov/types/testicular/patient/testicular-treatment-pdq> ;
  onco:tag "gap-fill", "genitourinary", "aya" ;
  onco:related <https://onco.cc/cancers/paediatric-germ-cell-tumours/> ;
  onco:technologies <https://onco.cc/technologies/platinum/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/survivorship-care-plan/> ;
  onco:targets <https://onco.cc/targets/tp53/> ;
  onco:drugs <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/vinblastine/> ;
  onco:terms <https://onco.cc/terms/afp/>, <https://onco.cc/terms/late-recurrence/>, <https://onco.cc/terms/retroperitoneum/> ;
  onco:journals <https://onco.cc/journals/journal-of-adolescent-and-young-adult-oncology/> ;
  onco:pipeline <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:standardOfCare <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/technologies/active-surveillance/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/bleomycin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/trials/getug-13/>, <https://onco.cc/drugs/paclitaxel/>, <https://onco.cc/drugs/ifosfamide/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/> .